Prise en charge chirurgicale des hémorragies sous-rétiniennes secondaires à une vasculopathie polypoïdale

[1]  L A Yannuzzi,et al.  IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV) , 1990, Retina.

[2]  M. Tadarati,et al.  Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study , 2010, British Journal of Ophthalmology.

[3]  S. Kishi,et al.  Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy. , 2010, American journal of ophthalmology.

[4]  Y. Tano,et al.  One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. , 2010, Ophthalmology.

[5]  I. Yeo,et al.  Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy , 2009, Eye.

[6]  H. Iijima,et al.  Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy. , 2008, American journal of ophthalmology.

[7]  Y. Tano,et al.  Polypoidal choroidal vasculopathy and treatments , 2008, Current opinion in ophthalmology.

[8]  A. Negi,et al.  Elastin gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. , 2008, Investigative ophthalmology & visual science.

[9]  Akira Negi,et al.  LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. , 2007, American journal of ophthalmology.

[10]  Y. Tano,et al.  Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy , 2007, British Journal of Ophthalmology.

[11]  Y. Tano,et al.  Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[12]  A. Eller,et al.  The Therapeutic Effects of Intravitreal Bevacizumab in a Patient with Recalcitrant Idiopathic Polypoidal Choroidal Vasculopathy , 2007, Seminars in ophthalmology.

[13]  R. P. Singh,et al.  Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator , 2006, British Journal of Ophthalmology.

[14]  C. Awh,et al.  Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration. , 2004, Ophthalmology.

[15]  P. Yu,et al.  Retinal toxicity of intravitreal tenecteplase in the rabbit , 2004, British Journal of Ophthalmology.

[16]  M. Matsumura,et al.  Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. , 2003, Archives of ophthalmology.

[17]  San-Ni Chen,et al.  Retinal toxicity of intravitreal tissue plasminogen activator: case report and literature review. , 2003, Ophthalmology.

[18]  L. Hattenbach,et al.  Intravitreale Gabe von rt-PA und Gas zur Behandlung kleinflächiger subfovealer Blutungen bei altersbezogener Makuladegeneration , 2002 .

[19]  M. Matsumura,et al.  Polypoidal choroidal vasculopathy: natural history. , 2002, American journal of ophthalmology.

[20]  T. Cox,et al.  Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration. , 2001, American journal of ophthalmology.

[21]  M. Hope-Ross,et al.  Idiopathic polypoidal choroidal vasculopathy: A disease with diverse clinical spectrum and systemic associations , 2000, Eye.

[22]  K. Bartz-Schmidt,et al.  POLYPOIDAL CHOROIDAL VASCULOPATHY PATTERN IN AGE‐RELATED MACULAR DEGENERATION: A Clinicopathologic Correlation , 2000, Retina.

[23]  M. Kamei,et al.  A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits. , 1999, American journal of ophthalmology.

[24]  L A Yannuzzi,et al.  Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. , 1999, Archives of ophthalmology.

[25]  T. Matsuo,et al.  Surgical treatment of submacular hemorrhage associated with idiopathic polypoidal choroidal vasculopathy. , 1999, American journal of ophthalmology.

[26]  Y. Tano,et al.  Pneumatic Displacement of Subretinal Hemorrhage Without Tissue Plasminogen Activator , 1998 .

[27]  S. Saika,et al.  Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhage , 1998, Graefe's Archive for Clinical and Experimental Ophthalmology.

[28]  M. Hochman,et al.  Pathophysiology and management of subretinal hemorrhage. , 1997, Survey of ophthalmology.

[29]  L. Hesse,et al.  Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas. , 1997, Advances in therapy.

[30]  Y. Tano,et al.  Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. , 1996, American journal of ophthalmology.

[31]  H. Lewis,et al.  Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. , 1994, American journal of ophthalmology.

[32]  M. Landers,et al.  Fibrinolytic-assisted removal of experimental subretinal hemorrhage within seven days reduces outer retinal degeneration. , 1994, Ophthalmology.

[33]  J. Vander.  Tissue plasminogen activator irrigation to facilitate removal of subretinal hemorrhage during vitrectomy. , 1992, Ophthalmic surgery.

[34]  E. Hernandez,et al.  Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage. , 1992, Ophthalmology.

[35]  M. Landers,et al.  Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat. , 1991, Archives of ophthalmology.

[36]  M. Landers,et al.  Fibrin Directs Early Retinal Damage After Experimental Subretinal Hemorrhage , 1991 .

[37]  J. Flannery,et al.  Tissue plasminogen activator treatment of experimental subretinal hemorrhage. , 1991, American journal of ophthalmology-glaucoma.

[38]  Z. Zakov,et al.  Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. , 1985, American journal of ophthalmology.

[39]  L. Yannuzzi,et al.  Polypoidal choroidal vasculopathy. , 2004, Survey of ophthalmology.

[40]  Matthew A. Thomas,et al.  Surgical Management of Submacular Hemorrhage: A Series of 47 Consecutive Cases , 1995 .

[41]  Mark W. Johnson,et al.  TISSUE PLASMINOGEN ACTIVATOR TREATMENT OF EXPERIMENTAL SUBRETINAL HEMORRHAGE , 1991, Retina.